- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Post-cardiac arrest syndrome.
Displaying page 1 of 1.
EudraCT Number: 2014-002998-11 | Sponsor Protocol Number: ENDO-RCA | Start Date*: 2014-11-14 | |||||||||||
Sponsor Name:Rigshospitalet, Capital Region Bloodbank 2034, Section for Transfusion Medicine | |||||||||||||
Full Title: Safety and efficacy of low-dose Iloprost administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac- arrest-syndrome patients... | |||||||||||||
Medical condition: Cardiac Arrest | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002514-32 | Sponsor Protocol Number: NPT-CL-01 | Start Date*: 2018-09-12 | |||||||||||
Sponsor Name:NeuroproteXeon, Inc. | |||||||||||||
Full Title: XePOHCAS: Prospective, randomized, multicenter, interventional trial in adult subjects with out-of-hospital cardiac arrest (OHCA) comparing treatment with standard-of-care post-cardiac arrest inten... | |||||||||||||
Medical condition: Post-cardiac arrest syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) DE (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004318-25 | Sponsor Protocol Number: NL63681.029.18 | Start Date*: 2019-04-16 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: Early high-dose vitamin C in post-cardiac arrest syndrome. | |||||||||||||
Medical condition: Patients admitted to the Intensive Care after out-of-hospital cardiac arrest with return of spontaneous circulation, ventricular fibrillation or ventricular tachycardia as first registered cardiac ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000202-35 | Sponsor Protocol Number: I13018 | Start Date*: 2015-01-30 | |||||||||||
Sponsor Name:CHU de LIMOGES | |||||||||||||
Full Title: Prevention of early ventilator-associated pneumonia with antibiotic therapy in patients treated with mild therapeutic hypothermia after cardiac arrest. Randomized, multicenter double-blind placeb... | |||||||||||||
Medical condition: Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001620-33 | Sponsor Protocol Number: APHP200033 | Start Date*: 2021-01-13 |
Sponsor Name:ASSISTANCE-PUBLIQUE HOPITAUX DE PARIS (AP-HP) | ||
Full Title: HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome | ||
Medical condition: Adult cardiac arrest patients with sustained ROSC and hemodynamic failure due to post-resuscitation syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004319-29 | Sponsor Protocol Number: P170914J | Start Date*: 2021-10-04 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: " LEVOSIMENDAN to facilitate weaning from ECMO in severe cardiogenic shock patients | |||||||||||||
Medical condition: Adult patients with acute cardiogenic shock refractory to conventional therapy placed on VA-ECMO support and for whom withdrawal from ECMO is possible. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003259-24 | Sponsor Protocol Number: 0360 | Start Date*: 2015-12-07 | |||||||||||
Sponsor Name:University of Leicester | |||||||||||||
Full Title: The Effect of Sildenafil (REVATIO®) on Post Cardiac Surgery Acute Kidney Injury: A Randomised, Placebo-controlled Phase IIb Clinical Trial: The REVAKI-2 Trial | |||||||||||||
Medical condition: Post cardiac surgery acute kidney injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
